1. Home
  2. LPTX vs GRO Comparison

LPTX vs GRO Comparison

Compare LPTX & GRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LPTX
  • GRO
  • Stock Information
  • Founded
  • LPTX 2011
  • GRO 2006
  • Country
  • LPTX United States
  • GRO Canada
  • Employees
  • LPTX N/A
  • GRO N/A
  • Industry
  • LPTX Biotechnology: Biological Products (No Diagnostic Substances)
  • GRO
  • Sector
  • LPTX Health Care
  • GRO
  • Exchange
  • LPTX Nasdaq
  • GRO NYSE
  • Market Cap
  • LPTX 119.6M
  • GRO 95.8M
  • IPO Year
  • LPTX N/A
  • GRO 2024
  • Fundamental
  • Price
  • LPTX $0.34
  • GRO $2.93
  • Analyst Decision
  • LPTX Buy
  • GRO Strong Buy
  • Analyst Count
  • LPTX 2
  • GRO 1
  • Target Price
  • LPTX $8.00
  • GRO $17.00
  • AVG Volume (30 Days)
  • LPTX 5.9M
  • GRO 161.7K
  • Earning Date
  • LPTX 03-26-2025
  • GRO 05-03-2025
  • Dividend Yield
  • LPTX N/A
  • GRO N/A
  • EPS Growth
  • LPTX N/A
  • GRO N/A
  • EPS
  • LPTX N/A
  • GRO N/A
  • Revenue
  • LPTX N/A
  • GRO N/A
  • Revenue This Year
  • LPTX N/A
  • GRO N/A
  • Revenue Next Year
  • LPTX N/A
  • GRO N/A
  • P/E Ratio
  • LPTX N/A
  • GRO N/A
  • Revenue Growth
  • LPTX N/A
  • GRO N/A
  • 52 Week Low
  • LPTX $0.28
  • GRO $2.18
  • 52 Week High
  • LPTX $4.79
  • GRO $15.00
  • Technical
  • Relative Strength Index (RSI)
  • LPTX 33.17
  • GRO N/A
  • Support Level
  • LPTX $0.28
  • GRO N/A
  • Resistance Level
  • LPTX $0.65
  • GRO N/A
  • Average True Range (ATR)
  • LPTX 0.05
  • GRO 0.00
  • MACD
  • LPTX 0.02
  • GRO 0.00
  • Stochastic Oscillator
  • LPTX 16.22
  • GRO 0.00

About LPTX Leap Therapeutics Inc.

Leap Therapeutics Inc is in developing targeted antibody therapies for cancer treatment, focusing on inhibiting tumor-promoting pathways, targeting cancer-specific cell surface molecules, and activating the immune system against cancer cells. The company's lead program, DKN-01, targets Dickkopf-related protein 1 (DKK1) and is in clinical trials for esophagogastric, gynecologic, and colorectal cancers. Their second program, FL-301, targets Claudin18.2-expressing cells. Additionally, the company has two preclinical antibody programs, FL-302 and FL-501, aimed at developing transformative cancer treatments. Operating as a single segment, the company's sole focus is on developing innovative drugs to address unmet needs in cancer therapy. .

About GRO BRAZIL POTASH CORP

Brazil Potash Corp is a mineral exploration and development company with a potash mining project located in the state of Amazonas, Brazil. The company's technical operations are based in Autazes, Amazonas, Brazil, and Belo Horizonte, Minas Gerais, Brazil. The operating activities of the company includes focusing on the extraction and processing of potash ore from underground mine and selling and distributing the processed potash in Brazil.

Share on Social Networks: